Stock Offerings
Secondary · ATM · Shelf · PIPE Guide↗
1,203 results
1203
Total Filings
$7039.3B
Total Raised
101
424B4 Offerings
315
ATM Programs
257
PIPEs
| Date ▼ | Ticker | Sector | Industry | Mkt Cap | Type | Offer Price | Price | vs Offer | Shares | Proceeds | Underwriters | Summary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9 | ENGNW | — | — | — | ATM |
$8.71
floor
|
— | — | — | — | — | Engene Inc. may raise up to $100 million through an at-the-market offering of common shares via Leerink Partners, with proceeds for general corporate purposes. |
| Mar 9 | USEG | Energy | Oil & Gas Exploration & Production | $44M | Public Offering | — | $1.25 | — | 8.8M | — | — | U.S. Energy Corp. is offering 8,800,000 common shares at $1.00 per share, raising $8.8 million gross proceeds for general corporate purposes. |
| Mar 6 | TRNR | Consumer Cyclical | Personal Products & Services | $1M | ATM |
$11.40
floor
|
$2.31 | -79.7% | — | — | — | Interactive Strength Inc. is raising up to $6,057,000 through an at-the-market offering of common stock via H.C. Wainwright at $1.73/share; proceeds will replenish the shelf registration for future capital needs. |
| Mar 6 | ALOY | Basic Materials | Other Precious Metals | $555M | ATM | — | $8.14 | — | 260K | — | — | Real Alloyz Inc. (ALOY) suspended its at-the-market offering after selling 260,000 common shares for $2.21 million gross proceeds through Alexander Capital L.P. since July 2025. |
| Mar 6 | IBIO | Healthcare | Biotechnology | $18M | ATM | — | $1.17 | — | — | — | Jefferies | iBio may sell up to $100 million in common stock at market prices through Jefferies as sales agent, with proceeds for general corporate purposes. |
| Mar 6 | VENU | Consumer Cyclical | Restaurants | $90M | Public Offering |
$4.84
floor
|
$1.50 | -69.1% | — | — | — | Venu Holding Corporation is selling common stock and warrants at an undisclosed price per unit; specific share counts and proceeds use are blank in this preliminary prospectus supplement. |
| Mar 6 | BXP | Real Estate | REIT - Office | $9.9B | ATM | — | $61.98 | — | — | — | BofA, J.P. Morgan, Jefferies, Morgan Stanley, Truist, Wells Fargo | BXP, Inc. established a $1 billion at-the-market common stock offering program through thirteen sales agents, with proceeds for general corporate purposes and potential debt reduction. |
| Mar 6 | VCIG | Industrials | Consulting Services | $959,441 | Public Offering |
$5.62
floor
|
$1.55 | -72.4% | — | — | — | VCIG Global is raising $15 million from a single institutional investor through three tranches of $5 million each, selling ordinary shares, pre-funded warrants, and common warrants at $4.09 per share; proceeds will fund operations. |
| Mar 6 | CLDWW | — | — | — | Public Offering | — | — | — | — | — | — | # Calidi Biotherapeutics (CLDWW) Offering Summary **Calidi Biotherapeutics is conducting a firm commitment underwritten public offering of common stock units with Series J, K, and L warrants; specific price and proceeds allocation not disclosed in this preliminary prospectus supplement dated March 5, 2026.** |
| Mar 6 | STEM | Technology | Software - Infrastructure | $42M | Public Offering | — | $4.66 | — | — | — | Jefferies | Stem Inc. (STEM) is selling up to $30 million in common stock at-the-market pricing through Jefferies LLC as sales agent; proceeds will be used for general corporate purposes. |
| Mar 6 | ALZN | Healthcare | Biotechnology | $7M | ATM |
$2.43
floor
|
$1.84 | -24.3% | — | — | — | Alzamend Neuro (ALZN) may sell up to $3,000,000 of common stock at-the-market through Ascendiant Capital Markets at variable prices, with 3% commission; proceeds for general corporate purposes. |
| Mar 6 | NRIX | Healthcare | Biotechnology | $2.4B | Public Offering |
$15.22
floor
|
$23.36 | +53.4% | 4.6M | $71M | Piper Sandler | Nrix is selling up to $413.65 million in common stock through Piper Sandler via at-the-market offering; $113.65 million already sold; proceeds for general corporate purposes. |
| Mar 6 | DYAI | Healthcare | Biotechnology | $17M | ATM | — | $0.46 | — | — | — | — | Dyadic International selling up to $4.24 million in common stock through Craig-Hallum Capital Group via at-the-market offering at prevailing market prices; proceeds for general corporate purposes. |
| Mar 6 | INGM | Technology | Information Technology Services | $6.1B | Public Offering | — | $26.48 | — | — | — | Morgan Stanley, Goldman Sachs, J.P. Morgan, BofA, Deutsche Bank, Evercore | Platinum Equity's investment vehicle Ingram Holdco is selling 8,988,764 shares of Ingram Micro common stock at $26.29/share; company simultaneously repurchasing $75 million of shares. |
| Mar 5 | ACHR-WT | — | — | — | Public Offering | — | — | — | — | — | — | Archer Aviation is issuing up to $8,000,000 in Class A common stock to service providers as compensation for services, priced at five-day VWAP. |
| Mar 5 | CTNM | Healthcare | Biotechnology | $487M | ATM | — | $12.95 | — | — | $20M | — | Contineum (CTNM) is conducting an at-the-market offering of up to $100 million in Class A common stock through Leerink Partners as sales agent, with proceeds for general corporate purposes. |
| Mar 5 | TPET | Energy | Oil & Gas Exploration & Production | $8M | ATM | — | $1.69 | — | — | — | — | Trio Petroleum Corp is selling up to $4,000,000 of common stock through an ATM offering at market prices via Ladenburg Thalmann, with proceeds for general corporate purposes. |
| Mar 5 | ALOY | Basic Materials | Other Precious Metals | $555M | Public Offering | — | $8.14 | — | — | — | Needham | # ALOY Offering Summary Unable to extract specific offering details: the 424B5 prospectus supplement is incomplete with blank placeholders for share count, offering price, and proceeds allocation. |
| Mar 4 | IREN | Financial Services | Financial - Capital Markets | $14.8B | ATM |
$38.85
floor
|
$41.58 | +7.0% | — | — | B. Riley, Cantor Fitzgerald, Citigroup, J.P. Morgan, Goldman Sachs, Jefferies | IREN Limited established an at-the-market offering to sell up to $6 billion in ordinary shares through multiple sales agents, with proceeds for general corporate purposes. |
| Mar 4 | MAIA | Healthcare | Biotechnology | $71M | Public Offering |
$2.26
floor
|
$1.17 | -48.2% | 20.0M | $45M | — | MAIA Biotechnology is offering 20 million common shares at $1.50 per share to raise $30 million gross proceeds ($28.5 million net), with underwriter 5% discount. |
Data sourced from SEC EDGAR 424B4, 424B5, and 8-K filings. IPOs hidden by default.
Learn more →